Possible Treatment for Chronic Fatigue Syndrome - KCBD NewsChannel 11 Lubbock

5/13/02

Possible Treatment for Chronic Fatigue Syndrome

Doctors estimate there are more than a million people who suffer from Chronic Fatigue Syndrome. Those patients feel a continued sense of exhaustion, and they may suffer flu-like symptoms, trouble concentrating, and difficulty sleeping for long periods of time.

The cause of the syndrome is not known, but researchers at the University of Miami say they think they may have found a good reason for most cases. "In Chronic Fatigue about 60% to 70% of the individuals we found have a deficit in red blood cell production and it's not picked up by normal medical tests. It's not generally known in the medical community that there is this problem with the red blood cell production," said Barry Hurwitz, PhD of University of Miami.

Dr. Hurwitz says they have also found something that may be effective treatment for Chronic Fatigue. It is Procrit, a drug that is already used to treat anemia in cancer patients. They have been testing it at the University of Miami. Half the patients took Procrit for four months and the other half took a Placebo.

Jean Gaudreau was in the Procrit group and says she saw an incredible difference. "We had a party at our house for the first time in about four years. I felt that good. We had a Christmas tree for the first time in a number of years. I was able to clean the house. I was able to do functions. I could work. I was able to work a forty hour week. It was just amazing the changes," said Gaudreau.

The study continues in Miami. In fact, they are looking for more participants so if you suffer from Chronic Fatigue Syndrome and would like to join the Procrit study, you can call this number for more information, 305-325-7154. For more information (click here).

Powered by WorldNow

5600 Avenue A
Lubbock, TX. 79404

FCC Public File
publicfile@kcbd.com
806-744-1414
EEO Report
Closed Captioning

All content © Copyright 2000 - 2014 Worldnow and KCBD. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.